Cargando…
Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment
Interstitial fibrosis plays a key role in the development and progression of heart failure. Here, we show that an enzyme that crosslinks collagen—Lysyl oxidase-like 2 (Loxl2)—is essential for interstitial fibrosis and mechanical dysfunction of pathologically stressed hearts. In mice, cardiac stress...
Autores principales: | Yang, Jin, Savvatis, Konstantinos, Kang, Jong Seok, Fan, Peidong, Zhong, Hongyan, Schwartz, Karen, Barry, Vivian, Mikels-Vigdal, Amanda, Karpinski, Serge, Kornyeyev, Dmytro, Adamkewicz, Joanne, Feng, Xuhui, Zhou, Qiong, Shang, Ching, Kumar, Praveen, Phan, Dillon, Kasner, Mario, López, Begoña, Diez, Javier, Wright, Keith C., Kovacs, Roxanne L., Chen, Peng-Sheng, Quertermous, Thomas, Smith, Victoria, Yao, Lina, Tschöpe, Carsten, Chang, Ching-Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171850/ https://www.ncbi.nlm.nih.gov/pubmed/27966531 http://dx.doi.org/10.1038/ncomms13710 |
Ejemplares similares
-
Wnt signaling and Loxl2 promote aggressive osteosarcoma
por: Matsuoka, Kazuhiko, et al.
Publicado: (2020) -
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal
por: Ikenaga, Naoki, et al.
Publicado: (2017) -
Linking LOXL2 to Cardiac Interstitial Fibrosis
por: Erasmus, Melisse, et al.
Publicado: (2020) -
Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development
por: Santamaría, Patricia G., et al.
Publicado: (2022) -
LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
por: Ma, Hsiao-Yen, et al.
Publicado: (2023)